Loading…
History for this window is not loaded yet.
FMED and MTRA share 6.0% of their holdings.
| Side by side | FMED | MTRA |
|---|---|---|
| Strategy | Thematic · Disruptive tech | International · Ex-US broad |
| Expense ratio | 0.50% | 0.54% |
| Cost per year on $10k | $50 | $54 |
| Trailing 12-mo yield |
| 0.00% |
| 0.70% |
| Income per year on $10k | $0 | $70 |
| YTD | +23.7% | −1.6% |
| 1 year | +25.9% | −2.4% |
| 3 years · per year | +17.2% | — |
| 5 years · per year | — | — |
| Worst drop · 1Y | −18.3% | −15.8% |
| Volatility · 1Y | 23.0% | 19.2% |
| Holdings | 63 | 50 |
| Assets | $52M | $133M |
| Leverage | None | None |
| Since | 2020 | 2025 |
Highlighted = best in the row. Returns include dividends.